Cytomegalovirus Retinitis in a Patient with Large Cell Diffuse Non-Hodgkin’s Lymphoma
Abstract
Keywords
References
- 1. Egbert PR, Pollard RB, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts. Ocular manifestations. Ann Intern Med 1980;93:664–70.
- 2. Shahnaz S, Choksi MT, Tan IJ. Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and endstage renal disease. Mayo Clin Proc 2003;78:1412–5.
- 3. Evans BG. Management of blinding disease: loss of immunity and superinfection. Eye 2005;19:1035–6
- 4. Schlingemann RO, Wertheim-van Dillen P, Kijlstra A, Bos PJ, Meenken C, Feron EJ. Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus. Br J Ophthalmol 1996;80:1109–10.
- 5. Scott WJ, Giangiacomo J, Hodges KE. Accelerated cytomegalovirus retinitis secondary to immunosuppressive therapy. Arch Ophthalmol 1986;104:1117–8, 1124
- 6. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR: Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis 2008, 10:13–18.
- 7. Schachat AP: Non-Hodgkin’s lymphoma. In Gold DH, Weingest TA(eds): ‘‘The Eye in Systemic Disease.’’ Lippincott, 1990.
- 8. Martin DF, Sierra-Madero J, Walmsley S. Valganciclovir Study Group. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 2002; 346:1119–26.
Details
Primary Language
English
Subjects
Ophthalmology
Journal Section
Case Report
Authors
Ali Kal
*
0000-0001-7544-5790
Türkiye
Publication Date
August 30, 2021
Submission Date
June 14, 2021
Acceptance Date
September 29, 2021
Published in Issue
Year 2021 Volume: 3 Number: 2